These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1084 related items for PubMed ID: 12114422

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
    Pérez-Andres M, Almeida J, Martin-Ayuso M, Moro MJ, Martin-Nuñez G, Galende J, Hernandez J, Mateo G, San Miguel JF, Orfao A, Spanish Network on Multiple Myeloma, Spanish Network of Cancer Research Centers.
    Cancer; 2006 Mar 15; 106(6):1296-305. PubMed ID: 16475149
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status.
    Corso A, Castelli G, Pagnucco G, Lazzarino M, Bellio L, Klersy C, Bernasconi C.
    Haematologica; 1997 Mar 15; 82(1):43-6. PubMed ID: 9107081
    [Abstract] [Full Text] [Related]

  • 28. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M, Orfao A, Almeida J, Bladé J, González M, García-Sanz R, López-Berges C, Moro MJ, Hernández J, Escribano L, Caballero D, Rozman M, San Miguel JF.
    Am J Pathol; 1998 Jun 15; 152(6):1655-65. PubMed ID: 9626070
    [Abstract] [Full Text] [Related]

  • 29. Angiogenesis in multiple myeloma.
    Rajkumar SV, Kyle RA.
    Semin Oncol; 2001 Dec 15; 28(6):560-4. PubMed ID: 11740809
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K.
    Eur J Haematol; 2004 Jun 15; 72(6):410-5. PubMed ID: 15128419
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.
    Corso A, Arcaini L, Mangiacavalli S, Astori C, Orlandi E, Lorenzi A, Passamonti F, Klersy C, Pascutto C, Canevari-Sciorati A, Lazzarino M.
    Haematologica; 2001 Apr 15; 86(4):394-8. PubMed ID: 11325645
    [Abstract] [Full Text] [Related]

  • 38. Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients.
    Zdzisińska B, Wejksza K, Walter-Croneck A, Turski WA, Kandefer-Szerszeń M.
    Leuk Res; 2010 Jan 15; 34(1):38-45. PubMed ID: 19596432
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV, Gertz MA, Kyle RA.
    Cancer; 1998 Apr 15; 82(8):1501-5. PubMed ID: 9554527
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 55.